Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2022-04-26 00:00:00 ET · period of report 2022-04-26 · accession 0001104659-22-050560 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-26 | 2022-04-26 | PTGX | Gupta Suneel | Chief Development Off | M - OptEx | $7.38 | +40.0K | 117.6K | +52% | +$295.2K |
| D | 2022-04-26 | 2022-04-26 | PTGX | Gupta Suneel | Chief Development Off | M - OptEx | $0.00 | -40.0K | 70.0K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-26 | M | A | 40,000 | $7.38 | 117,561 | D | — | — | (F1) Includes an aggregate of 554 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2022. |
| 2 | Derivative | Stock Option (right to buy) | 2022-04-26 | M | D | 40,000 | $0.00 | 70,000 | D | $7.38 · — to 2029-01-14 | 40,000 Common Stock | (F2) The stock option vests over a four-year period, with 1/4th of the shares subject to the option vesting on January 15, 2020, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. |